• Guideline Summary
  • NGC:010878
  • 2015 Dec 16

Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis.

  • Guideline Summary
  • NGC:009274
  • 2012 Jun 18

Best evidence statement (BESt). Screening for uveitis in children with juvenile idiopathic arthritis (JIA).

  • Guideline Summary
  • NGC:009080
  • 2010 Aug (revised 2012 Feb)

Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198).

  • Guideline Summary
  • NGC:009219
  • 1995 (revised 2012)

ACR Appropriateness Criteria® limping child — ages 0-5 years.

Assessment and management of chronic pain.